An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets

PHASE3CompletedINTERVENTIONAL
Enrollment

994

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Type 2 Diabetes
Interventions
DRUG

Dapagliflozin

Tablets, Oral, Once daily, 24 weeks

DRUG

Metformin XR

Tablets, Oral, Once daily, 24 weeks

Trial Locations (99)

1100

Local Institution, Quezon City

1600

Local Institution, Pasig

1740

Local Institution, Las Piñas

1800

Local Institution, Marikina City

4114

Local Institution, Kiev

5000

Local Institution, Jaro Iloilo City

6000

Local Institution, Cebu City

10003

Local Institution, Zhytomyr

12401

Hudson Valley Clinical Research Center, Kingston

14000

Local Institution, Mexico City

17257

Biomedical Research Associates, Llc, Shippensburg

19522

Commonwealth Primary Care, Pc / Fleetwood Clinical Research, Fleetwood

20127

Local Institution, Aguascalientes

21010

Local Institution, Vinnytsia

28144

Crescent Medical Research, Salisbury

28209

Metrolina Medical Research, Charlotte

29303

Spartanburg Medical Research, Spartanburg

29605

Southeastern Research Associates, Inc., Greenville

31069

Middle Georgia Drug Study Center, Llc, Perry

32605

Florida Research Network, Llc, Gainesville

32701

Central Florida Clinical Trials, Inc., Altamonte Springs

33134

Clinical Therapeutics Corporation, Coral Gables

33145

Nextphase Clinical Trials, Inc., Miami

34000

Local Institution, Durango

34741

Fpa Clinical Research, Kissimmee

35242

Greystone Medical Research, Llc, Birmingham

35565

Winston Technology Research, Llc, Haleyville

37334

Middle Tennessee Clinical Research, Fayetteville

37660

Holston Medical Group, Kingsport

39159

Jackson Clinic, Rolling Fork

42090

Local Institution, Pachuca

43055

Newark Physician Associates, Newark

43701

Physician Research, Inc., Zanesville

44100

Local Institution, Guadalajara

44614

Community Health Care, Inc., Canal Fulton

44650

Local Institution, Guadalajara

44670

Local Institution, Guadalajara

45429

Wells Institute For Health Awareness, Kettering

49023

Local Institution, Dnipro

58070

Local Institution, Morelia

60061

Deerbrook Medical Associates, Vernon Hills

60607

Cedar Crosse Research Center, Chicago

63017

Mercy Medical Group/Dba Woodlake Research, Chesterfield

64000

Local Institution, Monterrey

64400

Local Institution, Monterrey, Nl

65009

Local Institution, Odesa

65039

Local Institution, Odesa

65114

Local Institution, Odesa

73008

Gilbert Medical Research, Llc, Bethany

73099

Integris Family Care Yukon, Yukon

73159

Integris Family Care South Penn, Oklahoma City

77004

Endocrine Associates, Houston

77024

Village Family Practice, Houston

77074

Non-Invasive Cardiovascular, Pa, Houston

77081

Excel Clinical Research, Llc, Houston

Texas Center For Drug Development, Houston

77584

Southwest Clinical Research Center, Llc, Pearland

78130

Hill Country Medical Associates, New Braunfels

78229

Covenant Clinical Research, Pa, San Antonio

S.A.M. Clinical Research Center, San Antonio

79010

Local Institution, Lviv

79705

Inst. Of Clin. Research At The Diabetes Cntr. Of The Sw, Midland

83003

Local Institution, Donetsk

85282

Clinical Research Advantage, Inc., Tempe

89000

Local Institution, Tampico

91910

Local Institution, Veracruz

92708

Southland Clinical Research Center, Inc., Fountain Valley

93720

Valley Research, Fresno

94520

John Muir Physician Network Clinical Research Center, Concord

97070

Local Institution, Mérida

97404

Willamette Valley Clinical Studies, Eugene

119048

Local Institution, Moscov

125299

Local Institution, Moscow

140091

Local Institution, Dzerzhinskiy

150003

Local Institution, Yaroslav

163045

Local Institution, Arkhangelsk

190068

Local Institution, Saint Petersburg

191015

Local Institution, Saint Petersburg

394018

Local Institution, Voronezh

400001

Local Institution, Volgograd

410028

Local Institution, Saratov

603018

Local Institution, Nizhny Novgorod

630091

Local Institution, Novosibirsk

630117

Local Institution, Novosibirsk

650066

Local Institution, Kemerovo

02914

Safe Harbor Clinical Research, East Providence

00983

Local Institution, Villa Fontana

00716

Local Institution, Ponce

00717

Local Institution, Ponce

00920

Local Institution, San Juan

00926

Local Institution, San Juan

471-701

Local Institution, Guri-si

Local Institution, Seoul

420-717

Local Institution, Bucheon-si

105-760

Local Institution, Incheon

400-711

Local Institution, Incheon

137-040

Local Institution, Seoul

463-070

Local Institution, Sungnam-Si, Gyeonggi-Do

04050

Local Institution, Kiev

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY